hotspot -WSS

hotspot

author：explore 2025-09-29 21:28:40 - browse：93

A woman uses her phone to scan a barcode. -- Health coverage from STAT — A Color Health service promises to make it easier to get cancer screenings. Color Health

Color Health wants to take away any reason you might have for skipping screenings for cancer.

The Silicon Valley company, which pivoted from cancer genomics to Covid-19 testing on a large and hugely profitable scale, has a new program that incorporates both its roots in cancer testing and its logistical experience from the pandemic. Called, simply, the Cancer Prevention and Screening Program, and built in partnership with the American Cancer Society, the program aims to make it easy to get the appropriate screenings, whether at a clinic or at home.

“If we can take away all your excuses for not doing the prevention, can we get you to do the prevention,” said Alicia Zhou, the company’s chief scientific officer. “It’s bringing the care to the patient, instead of bringing the patient to care.”

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： Malaria cases in Florida and Texas: Here’s what you need to know
Next article： An exit interview with Bristol Myers Squibb CEO Giovanni Caforio

WSS

Testing for cancer recurrence creates a new limbo for patients

Readout Newsletter: XBI biotech index, Akero Therapeutics

Hospitals warn Medicare's drug payment fix is ‘unlawful’

The pink breast cancer awareness ribbon needs a redesign

Millions may soon lose Medicaid when they don't have to

Xenotransplantation trials will require adjusting expectations, experts say

entertainment

hotspot

hotspot

At least 13 dead in Texas as scorching temps continue

Eli Lilly to pay $200M for Beam’s stake in gene

Affirmative action in medical school literally saved lives

Traditional Chinese medicine benefits explored in new JAMA study

As demand for Covid shots wanes, Moderna seeks its next success

Traditional Chinese medicine benefits explored in new JAMA study

FDA approval of Sarepta Duchenne genetic therapy gives me hope

Eli Lilly’s Mounjaro succeeds in second weight

What does generative AI mean for health care? We asked experts

Sea level rise could wash away turtle breeding grounds around the world, researchers say

leisure time

The pink breast cancer awareness ribbon needs a redesign

The thinking behind the controversial eating disorder chatbot Tessa

Altering the blood type of lungs raises potential for universal organs for transplants

Pioneering cancer drug will cost $475,000. Analysts call it a bargain

Canadian wildfire dangers should prompt more proactive mitigation from government: Experts

Millions may soon lose Medicaid when they don't have to

focus

explore

focus

explore